Click here for additional news beyond press releases.


Current | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000


December 5, 2007
Celera to Webcast Panel Discussion at the RBC Capital Markets Healthcare Conference
November 21, 2007
Celera to Webcast Presentation at the Piper Jaffray Healthcare Conference
November 20, 2007
Celera and Ipsen enter research collaboration to develop pharmacogenomic tests
November 15, 2007
Applera Appoints New Director
October 24, 2007
Celera Reports First Quarter Fiscal 2008 Results
additional: Applera Corporation Teleconference October 24, 2007 Management Remarks for First Quarter Fiscal 2008 Earnings Call
October 23, 2007
Celera Completes Acquisition of Atria Genetics, Inc.
October 15, 2007
Celera Completes Acquisition of Berkeley HeartLab, Inc.
October 15, 2007
Celera and Collaborators Identify a Five-gene Genetic Risk ScoreTM that Predicts Risk of Coronary Heart Disease
October 12, 2007
Applied Biosystems Group and Celera Group First Quarter Fiscal 2008 Financial Results and Conference Call Scheduled for October 24, 2007
September 28, 2007
Celera Grants Real Time PCR License to Siemens
September 28, 2007
Celera Announces Clinical Milestone Payment From Merck
September 20, 2007
Celera to Webcast Presentation at the UBS Global Life Sciences Conference
September 20, 2007
Celera to Acquire Atria Genetics, Inc.
September 17, 2007
Celera and Collaborators Identify Gene Variants Predicting Susceptibility to, and Severity of, Rheumatoid Arthritis
September 17, 2007
Celera Enters Oncology Research Collaboration with Merck to Develop Pharmacogenomic Tests
September 4, 2007
Celera to Acquire Berkeley HeartLab, Inc.
additional: Management Remarks on Celera’s acquisition of Berkeley HeartLab
September 4, 2007
Celera to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
August 9, 2007
Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
August 8, 2007
Applera Retains Morgan Stanley to Explore Potential Corporate Restructuring
July 25, 2007
Celera Reports Fourth Quarter and Fiscal 2007 Results
additional: Applera Corporation Teleconference July 25, 2007 Management Remarks for Fourth Quarter and Fiscal 2007 Earnings Call
July 16, 2007
Applied Biosystems Group and Celera Group Fourth Quarter and Fiscal 2007 Financial Results and Conference Call Scheduled for July 25, 2007
June 21, 2007
Abbott’s RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
June 14, 2007
Celera and Collaborators Discover a Genetic Marker Associated with Severe Coronary Artery Disease
June 13, 2007
Celera to Webcast Presentation at Piper Jaffray Second Annual London Health Care Conference
May 11, 2007
Abbott's HIV-1 Viral Load Test Approved by FDA for Use on New m2000 Molecular Diagnostics Instrument
April 27, 2007
Celera Publishes Data Validating Cirrhosis Risk Score as a Predictor of Cirrhosis in Chronic Hepatitis C Patients
April 26, 2007
Celera Reports Third Quarter Fiscal 2007 Results
additional: Applera Corporation Teleconference April 26, 2007 Management remarks for Third Quarter Fiscal 2007 Earnings Call
April 25, 2007
Celera and LabCorp® Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
April 25, 2007
Celera to Webcast Presentation at Morgan Stanley Healthcare Conference
April 16, 2007
Applied Biosystems Group and Celera Group Third Quarter Fiscal 2007 Financial Results and Conference Call Scheduled for April 26, 2007
March 7, 2007
Celera to Webcast Presentation at Cowen & Co Healthcare Conference
February 28, 2007
Applied Biosystems and Celera to Webcast Investor Meetings
February 27, 2007
Celera Identifies Novel Genes Associated with Late-Onset Alzeimer's Disease
February 22, 2007
Celera Presents Data Validating Its Metastasis Score as a Molecular Prognostic Tool in Breast Cancer
February 6, 2007
Celera to Webcast Presentation at BIO CEO & Investor Conference
January 25, 2007
Celera Reports Second Quarter Fiscal 2007 Results
additional: Applera Corporation Teleconference January 25, 2007 Management remarks for Second Quarter Fiscal 2007 Earnings Call
January 15, 2007
Applied Biosystems Group and Celera Group Second Quarter Fiscal 2007 Financial Results and Conference Call Scheduled for January 25, 2007
January 8, 2007
Abbott m2000™ Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada
January 2, 2007
Celera to Webcast Presentation at the JPMorgan Healthcare Conference